POPE study: rationale and methodology of a study to phenotype patients with COPD in Central and Eastern Europe

References

• Goldcopd.com [homepage on the Internet]Global Initiative for Chronic Obstructive Lung Disease; Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Diseasec2013 [updated January 2014; cited November 8, 2014]. Available from: http://www.goldcopd.org/uploads/users/files/GOLD_Report_2014_Jun11.pdfAccessed November 8, 2014
   Google Scholar
• Erswhitebook.org [homepage on the Internet]European Lung White Book; European Respiratory Society2013 [updated 2015; cited August 6, 2015]. Available from: http://www.erswhitebook.org/chapters/chronic-obstructive-pulmonary-disease/Accessed August 6, 2015
   Google Scholar
• BuistASMcBurnieMAVollmerWMInternational variation in the prevalence of COPD (the BOLD Study): a population-based prevalence studyLancet2007370958974175017765523
   PubMed Web of Science ®Google Scholar
• Whoint [homepage on the Internet]Chronic obstructive pulmonary disease (COPD)World Health Organisation2007 [updated January 2015; cited August 6, 2015]. Available from: http://www.who.int/mediacentre/factsheets/fs315/en/Accessed August 6, 2015
   Google Scholar
• LopezADShibuyaKRaoCChronic obstructive pulmonary disease: current burden and future projectionsEur Respir J200627239741216452599
   PubMed Web of Science ®Google Scholar
• QaseemAWiltTJWeinbergerSEDiagnosis and management of stable chronic obstructive pulmonary disease: a clinical practice guideline update from the American College of Physicians, American College of Chest Physicians, American Thoracic Society, and European Respiratory SocietyAnn Intern Med2011155317919121810710
   PubMed Web of Science ®Google Scholar
• De MarcoRAccordiniSAntòJMLong-term outcomes in mild/moderate chronic obstructive pulmonary disease in the European Community Respiratory Health SurveyAm J Respir Crit Care Med20091801095696319696441
   PubMed Web of Science ®Google Scholar
• GouldNSMinEGauthierSAging adversely affects the cigarette smoke–induced glutathione adaptive response in the lungAm J Respir Crit Care Med201018291114112220622027
   PubMed Web of Science ®Google Scholar
• BarrechegurenMEsquinasCMiravitllesMThe asthma-chronic obstructive pulmonary disease overlap syndrome (ACOS): opportunities and challengesCurr Opin Pulm Med2015211747925405671
   PubMed Web of Science ®Google Scholar
• Soler-CataluñaJJCosíoBIzquierdoJLConsensus document on the overlap phenotype COPD-asthma in COPDArch Bronconeumol201248933133722341911
   PubMed Web of Science ®Google Scholar
• WeissSTWhat genes tell us about the pathogenesis of asthma and chronic obstructive pulmonary diseaseAm J Respir Crit Care Med2010181111170117320133923
   PubMed Web of Science ®Google Scholar
• MatkovicZTudoricNMiravitllesMImpact of chronic bronchial infection in the lung and beyondEur Respir Mon2013604657
   Google Scholar
• HnizdoESullivanPABangKMWagnerGAssociation between chronic obstructive pulmonary disease and employment by industry and occupation in the US population: a study of data from the Third National Health and Nutrition Examination SurveyAm J Epidemiol2002156873874612370162
   PubMed Web of Science ®Google Scholar
• Torres-DuqueCMaldonadoDPérez-PadillaRBiomass fuels and respiratory diseasesProc Am Thorac Soc20085557759018625750
   PubMedGoogle Scholar
• LeuppiJDSchuetzPBingisserRShort-term vs conventional glucocorticoid therapy in acute exacerbations of chronic obstructive pulmonary disease: the REDUCE randomized clinical trialJAMA2013309212223223123695200
   PubMed Web of Science ®Google Scholar
• QaseemAHopkinsRKuttyKhomepage on the InternetManagement of Chronic Obstructive Pulmonary Disease: Review of the Performance Measures by the Performance Measurement Committee of the American College of PhysiciansAmerican College of Physicians2015 [updated 2015; cited August 6, 2015]. Available from: http://www.acponline.org/clinical_information/performance_measurement/measures/pmc_copd_review.pdfAccessed August 6, 2015
   Google Scholar
• TashkinDPRennardSIUryniakTEffect Of Budesonide/Formoterol (BUD/FM) Versus FM Alone On The Rate Of Exacerbations (Either Including Or Excluding The Use Of Antibiotics As Part Of Exacerbation Definition), Lung Function, And Rescue Medication Use In Patients With Moderate To Very Severe Chronic Obstructive Pulmonary Disease (COPD). B39 COPD exacerbations: precipitating factors, prevention, and outcome [homepage on the Internet]American Thoracic Society2014A2882A2882 c1998–2015 [updated 2015; cited August 6, 2015]. Available from: http://www.atsjournals.org/doi/abs/10.1164/ajrccm-conference.2014.189.1_MeetingAbstracts.A2882Accessed August 6, 2015
   Google Scholar
• MontuschiPMalerbaMSantiniGMiravitllesMPharmacological treatment of chronic obstructive pulmonary disease: from evidence-based medicine to phenotypingDrug Discov Today201419121928193525182512
   PubMed Web of Science ®Google Scholar
• DongYHLinHHShauWYComparative safety of inhaled medications in patients with chronic obstructive pulmonary disease: systematic review and mixed treatment comparison meta-analysis of randomised controlled trialsThorax2013681485623042705
   PubMed Web of Science ®Google Scholar
• WedzichaJADecramerMFickerJHAnalysis of chronic obstructive pulmonary disease exacerbations with the dual bronchodilator QVA149 compared with glycopyrronium and tiotropium (SPARK): a randomised, double-blind, parallel-group studyLancet Respir Med20131319920924429126
   PubMed Web of Science ®Google Scholar
• BarnesNCalverleyPMKaplanARabeKFChronic obstructive pulmonary disease and exacerbations: patient insights from the global Hidden Depths of COPD surveyBMC Pulm Med2013135423971625
   PubMed Web of Science ®Google Scholar
• EmermanCLEffectiveness of inhaled steroids in the management of chronic obstructive pulmonary diseaseCurr Emerg Hosp Med Rep201314189192
   Google Scholar
• JayaramLWongCMcAuleySCombined therapy with tiotropium and formoterol in chronic obstructive pulmonary disease: effect on the 6-minute walk testCOPD201310446647223875741
   PubMedGoogle Scholar
• CharlsonMEPompeiPAlesKLMacKenzieCRA new method of classifying prognostic comorbidity in longitudinal studies: development and validationJ Chronic Dis19874053733833558716
   PubMedGoogle Scholar
• Thoracic.org [homepage on the Internet]ATS documents: statements, guidelines & reports. American Thoracic Society1998–2015 [updated 2015; cited February 12, 2015]. Available from: http://www.thoracic.org/statements/Accessed February 12, 2015
   Google Scholar
• BestallJCPaulEAGarrodRUsefulness of the Medical Research Council (MRC) dyspnoea scale as a measure of disability in patients with chronic obstructive pulmonary diseaseThorax199954758158610377201
   PubMed Web of Science ®Google Scholar
• JonesPWHardingGBerryPDevelopment and first validation of the COPD assessment testEur Respir J200934364865419720809
   PubMed Web of Science ®Google Scholar
• MiravitllesMBarrechegurenMRoman-RodriguezMFrequency and characteristics of different clinical phenotypes of COPDInt J Tuberc Lung Dis201519899299826162367
   PubMed Web of Science ®Google Scholar
• MiravitllesMSoler-CataluñaJJCalleMSorianoJBTreatment of COPD by clinical phenotypes: putting old evidence into clinical practiceEur Respir J20134161252125623060631
   PubMed Web of Science ®Google Scholar
• HigginsVPriceDBakerCLReal-world characterization and differentiation of the Global Initiative for Chronic Obstructive Lung Disease strategy classificationInt J Chron Obstruct Pulmon Dis2014955156124920893
   PubMed Web of Science ®Google Scholar
• BangKMChronic obstructive pulmonary disease in nonsmokers by occupation and exposure: a brief reviewCurr Opin Pulm Med201521214915425590955
   PubMed Web of Science ®Google Scholar
• ZielinskiJBednarekMGóreckaDIncreasing COPD awarenessEur Respir J200627483385216585092
   PubMed Web of Science ®Google Scholar
• NadkarniPMBrandtCMFrawleySManaging attribute – value clinical trials data using the ACT/DB client – server database systemJ Am Med Inform Assoc1998521391519524347
   PubMed Web of Science ®Google Scholar
• NadkarniPMBrandtCMMarencoLWebEAV: automatic metadata-driven generation of web interfaces to entity-attribute-value databasesJ Am Med Inform Assoc20007434335610887163
   PubMed Web of Science ®Google Scholar
• NadkarniPMMarencoLEasing the transition between attribute-value databases and conventional databases for scientific dataProc AMIA Symp200148348711825235
   PubMedGoogle Scholar
• SchiaviEStirbulovRHernández VecinoRCOPD screening in primary care in four Latin American countries: methodology of the PUMA studyArch Bronconeumol2014501146947424816036
   PubMed Web of Science ®Google Scholar
• HanMKAgustiACalverleyPMChronic obstructive pulmonary disease phenotypesAm J Respir Crit Care Med2010182559860420522794
   PubMed Web of Science ®Google Scholar
• LeeYMChronic obstructive pulmonary disease: respiratory review of 2014Tuberc Respir Dis (Seoul)201477415516025368660
   PubMedGoogle Scholar
• BlasiFChalmersJDAlibertiSCOPD and bronchiectasis: phenotype, endotype or co-morbidityCOPD201411660360425384083
   PubMedGoogle Scholar
• NovotnaBKoblizekVZatloukalJCzech multicenter research database of severe COPDInt J Chron Obstruct Pulmon Dis201491265127425419124
   PubMed Web of Science ®Google Scholar
• Allen-RameyFCGuptaSDiBonaventuraMDPatient characteristics, treatment patterns, and health outcomes among COPD phenotypesInt J Chron Obstruct Pulmon Dis2012777978723226014
   PubMed Web of Science ®Google Scholar
• KoblizekVChlumskyJZindrVChronic Obstructive Pulmonary Disease: official diagnosis and treatment guidelines of the Czech Pneumological and Phthisiological Society; a novel phenotypic approach to COPD with patient-oriented careBiomed Pap Med Fac Univ Palacky Olomouc Czech Repub2013157218920123733084
   PubMed Web of Science ®Google Scholar
• MiravitllesMSoler-CataluñaJJCalleMSpanish guideline for COPD (GesEPOC). Update 2014Arch Bronconeumol201450Suppl 111624507959
   PubMed Web of Science ®Google Scholar
• LouieSZekiAASchivoMThe asthma-chronic obstructive pulmonary disease overlap syndrome: pharmacotherapeutic considerationsExpert Rev Clin Pharmacol20136219721923473596
   PubMed Web of Science ®Google Scholar
• MiravitllesMSoler-CataluñaJJCaleMA new approach to grading and treating COPD based on clinical phenotypes: summary of the Spanish COPD guidelines (GesEPOC)Prim Care Respir J201322111712123443227
   PubMedGoogle Scholar
• BurgelPRPaillasseurJLPeeneBTwo distinct chronic obstructive pulmonary disease (COPD) phenotypes are associated with high risk of mortalityPLoS One2012712e5104823236428
   PubMed Web of Science ®Google Scholar
• Garcia-AymerichJGómezFPBenetMIdentification and prospective validation of clinically relevant chronic obstructive pulmonary disease (COPD) subtypesThorax201166543043721177668
   PubMed Web of Science ®Google Scholar
• MagnussenHDisseBRodriguez-RoisinRWithdrawal of inhaled glucocorticoids and exacerbations of COPDN Engl J Med2014371141285129425196117
   PubMed Web of Science ®Google Scholar
• RossiAGuerrieroMCorradoAWithdrawal of inhaled corticosteroids can be safe in COPD patients at low risk of exacerbation: a real-life study on the appropriateness of treatment in moderate COPD patients (OPTIMO)Respir Res2014157725005873
   PubMed Web of Science ®Google Scholar
• GershonASCampitelliMACroxfordRCombination long-acting β-agonists and inhaled corticosteroids compared with long-acting β-agonists alone in older adults with chronic obstructive pulmonary diseaseJAMA2014312111114112125226477
   PubMed Web of Science ®Google Scholar
• RennardSICalverleyPMGoehringUMReduction of exacerbations by the PDE4 inhibitor roflumilast-the importance of defining different subsets of patients with COPDRespir Res2011121821272339
   PubMed Web of Science ®Google Scholar
• Nizankowska-MogilnickaEMejzaFBuistASPrevalence of COPD and tobacco smoking in Malopolska region-results from the BOLD study in PolandPol Arch Med Wewn2007117940241018062562
   PubMedGoogle Scholar
• GolecMSkórskaCMackiewiczBRelationship between COPD and lower socioeconomic status in farmers from South-Eastern Poland (Lublin region)Rural Remote Health201414253124588301
   PubMed Web of Science ®Google Scholar
• Eea.europa.eu [homepage on the Internet]European environment agency; Air quality in Europe – 2014 report352015 [updated July 30, 2015; cited August 6, 2015]. Available from: http://www.eea.europa.eu/publications/air-quality-in-europe-2014Accessed August 6, 2015
   Google Scholar
• CampPGRamirez-VenegasASansoresRHCOPD phenotypes in biomass smoke-versus tobacco smoke-exposed Mexican womenEur Respir J201443372573424114962
   PubMed Web of Science ®Google Scholar
• DavidovaJPraznovcovaLLundborgCSPricing and reimbursement of pharmaceuticals in the Czech Republic and SwedenPharm World Sci2008301576417588212
   PubMedGoogle Scholar
• CelliBRMacNeeWAgustiAStandards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paperEur Respir J200423693294615219010
   PubMed Web of Science ®Google Scholar
• BellamyDBouchardJHenrichsenSInternational Primary Care Respiratory Group (IPCRG) guidelines: management of chronic obstructive pulmonary disease (COPD)Prim Care Respir J2006151485716701758
   PubMedGoogle Scholar
• JonesPWBrusselleGDal NegroRWPatient-centred assessment of COPD in primary care: experience from a cross-sectional study of health- related quality of life in EuropePrim Care Respir J201221332933622885563
   PubMedGoogle Scholar